MorphoSys ADR earnings beat by 8.84, revenue topped estimates
Slightly above 67% of MorphoSys' investor base is looking to short. The analysis of current outlook of investing in MorphoSys AG ADR suggests that many traders are alarmed regarding MorphoSys' prospects. MorphoSys' investing sentiment overview a quick insight into current market opportunities from investing in MorphoSys AG ADR. Many technical investors use MorphoSys AG ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MorphoSys |
MorphoSys ADR earnings beat by 8.84, revenue topped estimates
Read at investing.com
MorphoSys Fundamental Analysis
We analyze MorphoSys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
MorphoSys is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
MorphoSys AG ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MorphoSys stock to make a market-neutral strategy. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with similar companies.
Peers
MorphoSys Related Equities
NVCT | Nuvectis Pharma | 3.98 | ||||
KRON | Kronos Bio | 1.06 | ||||
IPSC | Century Therapeutics | 0.99 | ||||
CGEM | Cullinan Oncology | 0.83 | ||||
PCVX | Vaxcyte | 0.62 | ||||
LYRA | Lyra Therapeutics | 0.53 | ||||
RLYB | Rallybio Corp | 0.43 | ||||
MLYS | Mineralys Therapeutics, | 0.00 | ||||
EWTX | Edgewise Therapeutics | 0.00 | ||||
PMVP | Pmv Pharmaceuticals | 0.00 | ||||
REPL | Replimune | 0.00 | ||||
MRSN | Mersana Therapeutics | 0.00 | ||||
GBIO | Generation Bio | 0.00 | ||||
ELVN | Enliven Therapeutics | 0.94 | ||||
IMCR | Immunocore Holdings | 1.23 | ||||
ACLX | Arcellx | 1.52 | ||||
GLUE | Monte Rosa | 2.22 | ||||
GOSS | Gossamer Bio | 2.36 | ||||
CCCC | C4 Therapeutics | 2.64 | ||||
IMRX | Immuneering Corp | 3.86 | ||||
VTYX | Ventyx Biosciences | 6.30 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |